Industrifonden invests in breakthrough innovations across life sciences, software, deep tech, and growth-stage companies, emphasizing long-term value creation and global scalability. The fund specializes in patient capital, supporting companies through complexity and critical inflection points to enable them to scale globally. They focus on sectors like life science (therapeutics, diagnostics, and health technologies), software (vertical AI, enterprise software, and digital transformation), deep tech (energy systems, advanced materials, and planetary health), and growth-stage companies ready to win beyond their home markets.
Preferred startup development maturity for initial funding deployment.
Backing innovative companies with the potential to fundamentally reshape industries and create long-term value for society. Focus on patient capital, long-term support, and global scaling.
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
Investment Team (45)
Andreas Hiller

Andreas Söneby

Anna Haupt

Anna Ljungdahl
Birgitta Stymne Göransson
Björn Bergström
Caroline Wachtmeister

Caroline Wadstein
Catharina Tunberg
Charlotta Nilsson
Christian Salamon
Claes De Neergaard

Clara Norgren
Elena Vallin

Fredrik Lehmann
Hans Schambye

Iliam Barkino

Jakob Regberg
Johan Englund
John Sjölander
Jonas Jendi

Jonathan Ilicki
Karolina Bjurehed
Lars Henriksson

